This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmieder, R. E. Articles by Weihprecht, H. Search for Related Content PubMed PubMed Citation Articles by Schmieder, R. E. Articles by Weihprecht, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB SODIUM

(Circulation. 1996;94:1304-1309.)
© 1996 American Heart Association, Inc.

Articles

Angiotensin II Related to Sodium Excretion Modulates Left Ventricular Structure in Human Essential Hypertension

Roland E. Schmieder, MD; Matthias R.W. Langenfeld, MD; Anja Friedrich, RN; Hans P. Schobel, MD; Christoph D. Gatzka, MD; Horst Weihprecht, MD

the Department of Medicine IV/Nephrology, University of Erlangen-Nurnberg, Germany.

Background Urinary sodium excretion and angiotensin II (Ang II), which are linked in a physiological feedback mechanism, have both been described to be blood pressure-independent determinants of left ventricular hypertrophy in essential hypertension. We conducted a study to investigate the interaction of sodium excretion with Ang II and its potential impact on myocardial hypertrophy.

Methods and Results Sixty-eight patients (46 men and 22 women; mean age, 52±10 years) with untreated World Health Organization stage I to II essential hypertension were examined in a cross-sectional study. Left ventricular structure and function (two-dimensionally guided M-mode echocardiography), dietary sodium intake (as estimated by 24-hour urinary sodium excretion), and noninvasive ambulatory blood pressure over 24 hours (Spacelab 90207) were determined in parallel with plasma renin activity and plasma Ang II and serum aldosterone concentrations (radioimmunoassay). Twenty-four-hour urinary sodium excretion emerged as a strong correlate of relative wall thickness independent of 24-hour ambulatory blood pressure (partial r=.49, P<.001). Ang II concentrations were weakly correlated with septal wall thickness (r=.27, P<.05) and left ventricular mass (r=.25, P<.05). Patients with high Ang II concentrations in relation to sodium excretion had a greater left ventricular mass (318±77 versus 257±54 g, P<.02), posterior wall thickness (11.8±1.9 versus 10.5±0.8 mm, P<.02), and septal wall thickness (13.6±1.8 versus 11.9±1.3 mm, P<.01) than those with "relatively low" Ang II levels in relation to sodium excretion.

Conclusions Impaired suppression of the renin-Ang II system appeared to act as a stimulus for myocardial hypertrophy in hypertensive patients.

Key Words: angiotensin • sodium • ventricles • hypertrophy • hypertension

This article has been cited by other articles:

				R. E. Schmieder, C. Delles, A. Mimran, J. P. Fauvel, and L. M. Ruilope Impact of Telmisartan Versus Ramipril on Renal Endothelial Function in Patients With Hypertension and Type 2 Diabetes Diabetes Care, June 1, 2007; 30(6): 1351 - 1356. [Abstract] [Full Text] [PDF]

				R. E. Schmieder The role of non-haemodynamic factors of the genesis of LVH Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2610 - 2612. [Full Text] [PDF]

				K. Yasunari, K. Maeda, T. Watanabe, M. Nakamura, J. Yoshikawa, and A. Asada Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2116 - 2123. [Abstract] [Full Text] [PDF]

				E. H. Fleischmann, M. P. Schlaich, B. M. W. Schmidt, S. Oehmer, and R. E. Schmieder Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1758 - 1765. [Abstract] [Full Text] [PDF]

				C. Delles, J. Erdmann, J. Jacobi, K. F. Hilgers, E. Fleck, V. Regitz-Zagrosek, and R. E. Schmieder Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension J. Am. Coll. Cardiol., March 1, 2001; 37(3): 878 - 884. [Abstract] [Full Text] [PDF]

				A. Aviv Salt and Hypertension: The Debate That Begs the Bigger Question Arch Intern Med, February 26, 2001; 161(4): 507 - 510. [Full Text] [PDF]

				R. E. Schmieder, J. Erdmann, C. Delles, J. Jacobi, E. Fleck, K. Hilgers, and V. Regitz-Zagrosek Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans J. Am. Coll. Cardiol., January 1, 2001; 37(1): 175 - 182. [Abstract] [Full Text] [PDF]

				G.Y.H Lip, D.C Felmeden, F.L Li-Saw-Hee, and D.G Beevers Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'? Eur. Heart J., October 2, 2000; 21(20): 1653 - 1665. [PDF]